Tumor Tissue Analysis in Patients Receiving Imatinib Mesylate for Malignant Glioma

This study has been completed.
Sponsor:
Collaborator:
Information provided by:
National Cancer Institute (NCI)
ClinicalTrials.gov Identifier:
NCT00401024
First received: November 16, 2006
Last updated: July 24, 2010
Last verified: July 2009
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: No date given
  Primary Completion Date: June 2009 (Final data collection date for primary outcome measure)
Publications: